| Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
|---|
| 05/19/2005 | WO2005024025A8 Polyene polyketides and methods of production |
| 05/18/2005 | CN1616420A Process for producing ethyl creatine ester hydrochloride |
| 05/12/2005 | WO2005041928A1 Compositions and dosage forms for ehnanced absorption of iron |
| 05/12/2005 | WO2005041927A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 05/12/2005 | WO2005041926A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 05/12/2005 | WO2005041925A2 Compositions and dosage forms for enhanced absorption |
| 05/12/2005 | WO2005041924A2 Administration of levodopa and carbidopa |
| 05/12/2005 | WO2005041923A1 Compositions and dosage forms for enhanced absorption of metformin |
| 05/12/2005 | US20050100527 Liposomes for transfection of nucleic acids |
| 05/12/2005 | CA2543945A1 Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid |
| 05/12/2005 | CA2543238A1 Compositions and dosage forms for enhanced absorption |
| 05/12/2005 | CA2543227A1 Administration of levodopa and carbidopa |
| 05/12/2005 | CA2543185A1 Compositions and dosage forms for ehnanced absorption of iron |
| 05/12/2005 | CA2543181A1 Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 05/12/2005 | CA2543177A1 Compositions and dosage forms for enhanced absorption of metformin |
| 05/06/2005 | WO2005040092A1 Method for synthesis of acrylamide derivatives |
| 05/06/2005 | WO2005039494A2 Inhibitors of rnase p proteins as antibacterial compounds |
| 05/06/2005 | CA2542206A1 Method for synthesis of acrylamide derivatives |
| 05/04/2005 | CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 05/04/2005 | CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma |
| 04/28/2005 | WO2005037798A2 Amide or thiomide derivatives and their use in the treatment of pain |
| 04/28/2005 | CA2539632A1 Amide or thioamide derivatives and their use in the treatment of pain |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/26/2005 | US6884912 Combining an aqueous solution of cyanamide and hydrazine hydrate to form a reaction medium in presence of carbon dioxide, in a molar ratio of cyanamide to hydrazine used is smaller than 1, reacting to form aminoguanidine bicarbonate |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/20/2005 | EP1320534B1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1210330B1 Antibacterial agents |
| 04/14/2005 | WO2005033067A1 SALT OF 1,2,6,7,8,8A-HEXAHYDRO-β,δ,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-, (βR,δ R,1S,2S,6S,8S,8AR)- 1-NAPHTHALENEHEPTANOIC ACID WITH N,N-DIMETHYL-IMIDODICARBONIMIDIC DIAMIDE |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/13/2005 | CN1196672C Non-hydroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
| 04/07/2005 | US20050075513 Method for preparing nitrogen-containing compounds |
| 04/07/2005 | US20050075402 chemical intermediates for helicobacter pylori bactericides; 4-(4-hydroxyphenyl)ethyl benzoate; antiulcer agents |
| 04/07/2005 | CA2539753A1 Treating neuropathic pain with neuropeptide ff receptor 2 agonists |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 03/30/2005 | EP1150946B1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | CN1193984C Process for the preparation of 1,1,3,3,-tetramthyl guanidine hydrochloride |
| 03/22/2005 | CA2467249C Polyene polyketides, processes for their production and their use as pharmaceuticals |
| 03/17/2005 | WO2004106288A3 Ionic liquids containing guanidinium cations |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867208 Vitronectin receptor antagonists, their preparation and their use |
| 03/09/2005 | EP1512679A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/09/2005 | CN1191861C Medicinal compositions containing anti-Fas antibody |
| 03/03/2005 | US20050049428 Production of creatine esters using in situ acid production |
| 03/03/2005 | US20050049421 amidation; reacting an amine and an ester in the presence of a silylating agent as catalyst under mild conditions |
| 03/03/2005 | US20050049312 N-(1-adamantyl)alkyl]alkano-amidines, guanidines or N'-nitroguanidines; non-competitive receptor antagonists for the NMDA receptor |
| 03/02/2005 | EP1509254A1 New agents for magnetic imaging method |
| 03/02/2005 | CA2479613A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/01/2005 | US6861554 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same |
| 02/24/2005 | WO2005016994A1 Method for preparing polyalkylenebiguanidine salt |
| 02/24/2005 | US20050043569 preparing an amidine by reacting a NH group-containing compound with a nitrile in the presence of a silylating agent (trimethylsilyl trifluoromethanesulfonate); direct and efficient synthesis ; large-scale synthesis. |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | CN1583717A Biguanide derivative and preparing method thereof |
| 02/23/2005 | CN1190416C Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn. and use |
| 02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
| 02/17/2005 | WO2005014528A1 Straight-chain and branched-chain lipid compounds as selective inhibitors of cyclooxygenase-2, anti-inflammatory agents, and anti-cancer agents |
| 02/17/2005 | US20050038105 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/15/2005 | US6855702 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 02/14/2005 | WO2005024025A1 Polyene polyketides and methods of production |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | CN1188121C Therapeutic substituted guanidines |
| 02/02/2005 | EP1501791A1 Amino acid analogues |
| 02/02/2005 | CN1187056C Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/26/2005 | EP1500595A2 Method for protecting packed food products from spoilage during storage and package or pre-cut package for storing food products |
| 01/26/2005 | EP1311514B1 Compositions with vascular damaging activity |
| 01/26/2005 | CN1186331C Substituted 2, 4-diamino-1, 3, 5-triazines as herbicides |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/12/2005 | CN1562966A New method for preparing brufen arginine salt |
| 01/11/2005 | US6841702 Arylguanidine derivatives; antimetastasis and antitumor agents |
| 01/06/2005 | US20050004185 Polyene polyketides, processes for their production and their use as pharmaceuticals |
| 01/05/2005 | CN1560031A Process for synthesizing guanidine carbonate |
| 01/05/2005 | CN1182873C Arginine silicate inositol complex and use thereof |
| 01/04/2005 | US6838472 Substituted urea retinoid agonists |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 12/30/2004 | US20040266008 Obtained by cultivation of Streptomyces melanosporafaciens; biosynthesis; fungicides; antitumor agents; antiproliferative agents |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1289931B1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 12/29/2004 | CN1182109C ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
| 12/29/2004 | CA2529949A1 Antiviral compounds and methods |
| 12/23/2004 | US20040260089 reacting diphosphorus pentoxide, an organic base (melamine, guanidine, piperazine), and a water releasing agent (borax, aluminum or magnesium hydroxide, or oxalic or formic acid) to form polyphosphate salts; fire retardants for thermoplastic polyamide or polyester platics |
| 12/23/2004 | DE10325051A1 Ionische Flüssigkeiten mit Guanidinium-Kationen Ionic liquids with guanidinium cations |
| 12/22/2004 | EP1280766B1 Biocidal polymers based on guanidine salts |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |